Please try another search
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Name | Age | Since | Title |
---|---|---|---|
Jeanne Armstrong | - | - | Member of Advisory Board |
Ramanujam Venugopalan | - | - | Member of Advisory Board |
Debbie McKay | - | - | Member of Advisory Board |
Geoff Caplea | - | - | Member of Advisory Board |
Susan Rodriguez | 59 | 2023 | Director |
Laura Kohlhagen | - | - | Member of Advisory Board |
P. Gregory Garrison | 69 | 2015 | Executive Chairman of the Board |
Jonathan J. Judge | 69 | 2016 | Independent Director |
David B. Stevens | 60 | 2016 | Independent Director |
Elizabeth Ann Altman | 52 | 2020 | Independent Director |
Kim Franks | - | 2018 | Member of Advisory Board |
Shih-Yin Ho | 53 | 2023 | Interim Chief Executive Officer & Director |
Carol J. Zierhoffer | 63 | 2020 | Lead Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review